BVS vs SOLV: fair value comparison
Bioventus Inc. and Solventum Corporation · Updated 2026-08-31
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, BVS currently sits closer to the top of our discount ranking. BVS carries the stronger quality grade. SOLV carries the stronger momentum grade.
| BVS | SOLV | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $13.47 | $91.12 |
| 12-month range | $6.56–$13.47 | $64.35–$88.07 |
| Sector rank | #86 of 113 Healthcare | #87 of 113 Healthcare |
| Quality grade | D | F |
| Momentum grade | B | A |
| Leverage | Moderate | High |
| Margin trend | — | Contracting |
| Revenue growth | — | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: BVS fair value analysis · SOLV fair value analysis